Androgenetic alopecia drugs and male infertility: Evidence from pharmacovigilance and testicular transcriptomics

Zhuozhi Gong, Jing He, Qiujian Feng, Wenyu Chen, Yonglong Xu, Qingying Wang, Shengjing Liu · 2026

Read Androgenetic alopecia drugs and male infertility: Evidence from pharmacovigilance and testicular transcriptomics by Zhuozhi Gong, Jing He, Qiujian Feng, Wenyu Chen, Yonglong Xu, Qingying Wang, Shengjing Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0357154.txt.

Description

Zhuozhi Gong and six colleagues check whether hair loss drugs carry a hidden link to male infertility, in a 2026 PLOS ONE study. Finasteride, dutasteride, and minoxidil are widely used against pattern baldness, and scattered reports have raised fertility worries. The team combined drug safety databases with gene data from testicular tissue to look for both warning signals and a plausible biological route.

Safety reports from American and European systems, covering roughly two decades, showed reporting signals for all three drugs, strongest for finasteride. In tissue from infertile men, one gene, HIF1A, stood out as more active, including in sperm producing and hormone making cells, and its activity tracked with immune and wound healing pathways. The authors present HIF1A as a candidate worth laboratory follow up, not settled proof of harm.

Catalog record

CREATORZhuozhi Gong, Jing He, Qiujian Feng, Wenyu Chen, Yonglong Xu, Qingying Wang, Shengjing Liu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51733
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0357154

Browse the full library · About the Tower of Babel